The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
mRNA technology represents a cutting-edge therapeutic approach, utilizing messenger RNA to direct cells in manufacturing specific proteins essential for a variety of medical applications, including vaccines and gene therapies.
The rapid development and authorization of mRNA-based vaccines during the COVID-19 pandemic sparked renewed interest in this advanced technology, leading to market constraints on critical raw materials and manufacturing capacity.
Thermo Fisher Scientific has responded by implementing a flexible solutions model for mRNA vaccine and therapeutic development, covering the entire operational value chain, from early translational services to cold chain logistics.
Whether you require support with refining processes or adhering to cGMP standards, you have the flexibility to choose from our core mRNA service offerings and integrate additional upstream and downstream solutions as needed.
Download our fact sheet to learn more about Therma Fisher Scientific’s development and manufacturing services for mRNA.
